Partnering

In unique cases, we seek private partners to move our drug candidates into full drug development through a series of immediate innovators. We do so because of the amount of capital necessary to further develop these product candidates is beyond the resources of the NeuroDiscovery Center. Together, we can accelerate the development of a drug candidate toward an Investigational New Drug (IND) stage (e.g., LLC) and then into phase I/II clinical trials (e.g., C-Corp).